PERSKY MARLA
SEC insider (Form 3/4/5 filer). CIK 0001270354. Director at Xeris Biopharma Holdings, Inc. (XERS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in CHICAGO, IL.
Companies PERSKY MARLA has filed insider reports for
- Xeris Biopharma Holdings, Inc. (XERS): Director
PERSKY MARLA
CIK: 0001270354
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
XERS
Xeris Biopharma Holdings, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 4, 2026XERS
Xeris Biopharma Holdings, Inc.
AwardDirect24.2K shares- - Jun 3, 2026XERS
Xeris Biopharma Holdings, Inc.
SaleDirect15.5K shares at avg. $5.90$91K - Sep 11, 2025XERS
Xeris Biopharma Holdings, Inc.
SaleDirect15.5K shares at avg. $7.72$120K - Jun 4, 2025XERS
Xeris Biopharma Holdings, Inc.
AwardDirect50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 | XERS Xeris Biopharma Holdings, Inc. | Award | 24,193 | - | $0 | Direct |
| Jun 3, 2026 | XERS Xeris Biopharma Holdings, Inc. | Sale | 15,500 | $5.90 | $91,433 | Direct |
| Sep 11, 2025 | XERS Xeris Biopharma Holdings, Inc. | Sale | 15,500 | $7.72 | $119,610 | Direct |
| Jun 4, 2025 | XERS Xeris Biopharma Holdings, Inc. | Award | 50,000 | - | - | Direct |
1-4 of 4 transactions